Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 260-350-7 | CAS number: 56706-10-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1998-08-03 to 1998-08-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 998
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- 4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane
- EC Number:
- 260-350-7
- EC Name:
- 4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane
- Cas Number:
- 56706-10-6
- Molecular formula:
- C18H42O6S2Si2
- IUPAC Name:
- 4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane
- Reference substance name:
- S2
- IUPAC Name:
- S2
Constituent 1
Constituent 2
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor induced rat liver S9
- Test concentrations with justification for top dose:
- Exp 1:7.5-120 µg/ml -S9, 10-500 µg/ml +S9; exp 2: 5-80 µg/ml -S9
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification: recommended by Sponsor
Controlsopen allclose all
- Untreated negative controls:
- yes
- Remarks:
- test medium
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without activation
- Untreated negative controls:
- yes
- Remarks:
- test medium
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- cyclophosphamide
- Remarks:
- with activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 hours (with metabolic activation); 4, 18 and 28 hours (without metabolic activation)
- Expression time (cells in growth medium): 18 and 28 hours
- Fixation time (start of exposure up to fixation or harvest of cells): 18 and 28 hours
SPINDLE INHIBITOR (cytogenetic assays): Colcemid
STAIN (for cytogenetic assays): Giesma
NUMBER OF REPLICATIONS: Duplicate cultures; independent repeat experiment
NUMBER OF CELLS EVALUATED: 200 metaphases per experimental group per experiment were examined for structural chromosomal abnormalities. 1000 cells were scored to determine the mitotic index.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS
- Determination of polyploidy: yes
- Determination of endoreplication: no data
METABOLIC ACTIVATION:
- Aroclor induced rat liver S9 prepared from Wistar rats with 43.7 mg/ml protein.
- S9 mix included 10% S9 and cofactor solution including MgCl2, KCl, Glucose-6-phosphate and NADP. Final concentration of S9 in cultures was approximately 1%. - Evaluation criteria:
- A substance was considered negative when there was no statistically significant, biologically relevant and reproducible positive response at any test point, and no concentration related statistically significant and biologically relevant increase in structural chromosomal aberrations compared with the solvent control group.
- Statistics:
- Frequencies of metaphases with structural aberrations of test substance and positive control groups were compared with those of the solvent control group. A Chi squared test was applied.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- >50 % reduction in mitotic index at 40 μg/ml
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- >50 % reduction in mitotic index at 40 μg/ml (without metabolic activation); 100 μg/ml (with metabolic activation)
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no significant effect
- Effects of osmolality: no significant effect
- Evaporation from medium: no data
- Water solubility: no data
- Precipitation: non-interfering precipitate noted at 100 μg/ml and above.
- Other confounding effects: none
RANGE-FINDING/SCREENING STUDIES: preliminary range finding test was carried out and cytotoxicity determined: 40 μg/ml (without metabolic activation) and 100 μg/ml (with metabolic activation
COMPARISON WITH HISTORICAL CONTROL DATA: control results were within the range of historical controls
Any other information on results incl. tables
Table 1 Chromosome aberrations Experiment 1
Without metabolic activation 4 h treatment, 18 h sampling |
||||||
Treatment (μg/ml) |
Number of cells analysed |
Mitotic Index (mean of two cultures %) |
Number of cells with Aberrations |
% of cells with aberrations |
||
inc Gaps |
excl Gaps |
inc Gaps |
excl Gaps |
|||
01 |
100+++ |
31.0 |
7 |
7 |
7.0 |
7.0 |
02 |
200 |
51.0 |
15 |
11 |
7.5 |
5.5 |
15 |
200 |
29.0 |
16 |
10 |
8.0 |
5.0 |
30 |
200 |
37.0 |
11 |
8 |
5.5 |
4.0 |
60 |
192++ |
6.5 |
11 |
9 |
5.7 |
4.7 |
Positive control |
200 |
22.5 |
114** |
110** |
57.0 |
55.0 |
With metabolic activation 4 h treatment, 18 h sampling |
||||||
Treatment (μg/ml) |
Number of cells analysed |
Mitotic Index (mean of two cultures %) |
Number of cells with Aberrations |
% of cells with aberrations |
||
inc Gaps |
excl Gaps |
inc Gaps |
excl Gaps |
|||
01 |
200 |
78.5 |
16 |
12 |
8.0 |
6.0 |
02 |
200 |
106.5 |
13 |
9 |
6.5 |
4.5 |
31.6 |
200 |
70.5 |
12 |
8 |
6.0 |
4.0 |
100P |
200 |
106.0 |
22 |
16 |
11.0 |
8.0 |
60P |
200 |
28.5 |
21 |
18 |
10.5 |
9.0 |
Positive control |
200 |
56.0 |
49** |
47** |
24.5 |
23.5 |
With metabolic activation 4 h treatment, 28 h sampling |
||||||
Treatment (μg/ml) |
Number of cells analysed |
Mitotic Index (mean of two cultures %) |
Number of cells with Aberrations |
% of cells with aberrations |
||
inc Gaps |
excl Gaps |
inc Gaps |
excl Gaps |
|||
01 |
100+++ |
77.0 |
5 |
7 |
5.0 |
4.0 |
02 |
200 |
90.5 |
18 |
15 |
9.0 |
7.5 |
31.6 |
200 |
75.0 |
8 |
7 |
4.0 |
3.5 |
100P |
200 |
99.0 |
11 |
8 |
5.5 |
4.0 |
60P |
200 |
52.5 |
22 |
19 |
11.0 |
9.5 |
Positive control |
200 |
109.0 |
27 |
21 |
13.5 |
10.5 |
1Negative control with culture medium
2Negative control with solvent (DMSO)
++ maximum number of evaluable metaphases on the slides examined
+++ determined from one culture only
* p<0.05
* p <0.01
PPrecipitation Table 2 Chromosome aberrations Experiment 2
Without metabolic activation 18 h treatment, 18 h sampling |
||||||
Treatment (μg/ml) |
Number of cells analysed |
Mitotic Index (mean of two cultures %) |
Number of cells with Aberrations |
% of cells with aberrations |
||
inc Gaps |
excl Gaps |
inc Gaps |
excl Gaps |
|||
01 |
89+++ |
46.0 |
5 |
3 |
5.6 |
3.3 |
02 |
190++ |
32.5 |
11 |
7 |
5.8 |
3.7 |
10 |
142++ |
15.0 |
11 |
7 |
7.7 |
4.9 |
20 |
153++ |
16.0 |
10 |
7 |
6.5 |
4.6 |
40 |
200 |
8.0 |
11 |
7 |
5.5 |
3.5 |
Positive control |
108++ |
12.5 |
12.5 |
26** |
24.0 |
19.4 |
Without metabolic activation 28 h treatment, 28 h sampling |
||||||
Treatment (μg/ml) |
Number of cells analysed |
Mitotic Index (mean of two cultures %) |
Number of cells with Aberrations |
% of cells with aberrations |
||
inc Gaps |
excl Gaps |
inc Gaps |
excl Gaps |
|||
01 |
37+++ |
2.0 |
4 |
4 |
10.8 |
10.8 |
02 |
200 |
42.0 |
15 |
13 |
7.5 |
6.5 |
10 |
200 |
37.0 |
25 |
17 |
12.5 |
8.5 |
20 |
151++ |
43.5 |
6 |
4 |
4.0 |
2.6 |
40 |
88++ |
6.0 |
5 |
4 |
5.7 |
4.5 |
Positive control |
158++ |
27.5 |
5.** |
47** |
31.6 |
29.7 |
1Negative control with culture medium
2Negative control with solvent (DMSO)
++ maximum number of evaluable metaphases on the slides examined
+++ determined from one culture only
* p<0.05
* p <0.01
Applicant's summary and conclusion
- Conclusions:
- S2 has been tested according to OECD 473 and in compliance with GLP. No test substance-induced structural or numerical chromosomal aberrations were observed in Chinese hamster V79 fibroblasts when tested up to cytotoxic concentrations, with and without metabolic activation. The experiment was repeated and the results confirmed. Appropriate solvent and positive controls were included and gave expected results. It is considered that the substance is negative for cytogenicity under the conditions of the test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.